See the DrugPatentWatch profile for savella
Foremost, Savella is manufactured by Bausch Health Companies [1]. This company offers the medication for the treatment of fibromyalgia [2].
What is Savella used for?
Savella, with the active ingredient milnacipran, is prescribed to manage fibromyalgia. This condition causes widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues [2].
How does Savella work?
Milnacipran, the active component in Savella, is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is thought to work by increasing the levels of certain neurotransmitters in the brain that help regulate pain [3].
When does Savella's patent expire?
Information on Savella's patent exclusivity is available on DrugPatentWatch.com [4]. This resource tracks drug patents, providing details on when specific protections are set to end, which can influence the availability of generic versions.
Who are the competitors for Savella?
Several other medications are available for fibromyalgia treatment, including pregabalin (Lyrica), duloxetine (Cymbalta), and gabapentin [2]. These drugs also work through different mechanisms to alleviate fibromyalgia symptoms.
What are the potential side effects of Savella?
Common side effects reported for Savella include nausea, headache, constipation, dizziness, insomnia, hot flush, vomiting, and dry mouth [2]. It is important for patients to discuss any concerns or side effects with their healthcare provider.